journal article·2026-03Open access

Bilayer vascular grafts separately loaded with sodium copper chlorophyllin and keratin-based hydrogen sulfide donor with pro-endothelialization, anti-thrombogenicity, anti-inflammation, and anti-calcification properties

Yu Sun, Shunqi Hu, Lijuan Wang, Fubang Liang, Zeyi Zhou, Yuyuan Zhang, Yanjun Pan, Jian Shen, Meng Yin, Jiang Yuan

Abstract

The clinical utility of small-diameter vascular grafts (SDVGs) remains limited due to thrombosis, inflammation, and intimal hyperplasia, which compromise long-term patency. Mimicking the structures and functions of blood vessels, bilayer SDVGs with gradient pore sizes were fabricated, thereby preventing the infiltration of vascular smooth muscle cells (VSMCs) into the inner layer. Additionally, sodium copper chlorophyllin (SCC) was embedded in the inner layer, potentially generating NO from endogenous donors in the blood and regulating vascular cells. Keratin-based H 2 S donor of KSN was synthesized and then electrospun with poly(L-lactide-co-ε-caprolactone) (PLCL) to serve as the outer layer of the grafts. The bilayer grafts promoted rapid endothelialization by selectively enhancing the adhesion, proliferation, and migration of vascular endothelial cells (VECs) while inhibiting those of VSMCs. More importantly, the released NO and H 2 S synergistically enhanced the anti-thrombotic, anti-inflammatory, and anti-calcification properties of the grafts. Furthermore, the bilayer grafts maintained the contractile phenotype of VSMCs and polarized macrophages toward the M2 phenotype. The grafts achieved patency with negligible intimal hyperplasia and calcification in the rat abdominal aorta replacement models for 1 month of implantation. The grafts modulated VECs via the PI3K-AKT signaling pathway, focal adhesion, apoptosis, and regulation of actin cytoskeleton, while regulating VSMCs through gap junction, ECM-receptor interaction, adherens junction, focal adhesion, and PI3K-AKT signaling pathway. These bilayer grafts with rapid endothelialization, antithrombogenicity, anti-inflammation, and anti-calcification properties are promising candidates for tissue-engineered SDVGs. • Novel keratin-based donor of H 2 S was synthesized and subsequently electrospun to act as the outer layer of bilayer grafts to prolong the release of H 2 S. • Biosafety sodium copper chlorophyllin (SCC) was incorporated and subsequently electrospun to act as the inner layer of bilayer grafts to catalytic generation of NO. • Bilayer grafts promoted EC proliferation while inhibiting SMC proliferation. • Bilayer grafts accelerated endothelialization without intimal hyperplasia, thrombosis, and calcification in vivo.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Wound Healing and Treatments · Infectious Aortic and Vascular Conditions

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (66)

Show source-provided references
1. Technology insight: the evolution of tissue-engineered vascular grafts--from research to clinical practice10.1038/ncpcardio0930 ↗
2. Hybrid small-diameter vascular grafts: Anti-expansion effect of electrospun poly epsilon-caprolactone on heparin-coated decellularized matrices10.1016/j.biomaterials.2015.10.066 ↗
3. Tissue‐engineered vascular grafts: emerging trends and technologies10.1002/adfm.202100027 ↗
4. Atherosclerosis--an inflammatory disease10.1056/NEJM199901143400207 ↗
5. Phenotypic switching of vascular smooth muscle cells in atherosclerosis10.1161/JAHA.123.031121 ↗
6. Dialysis arteriovenous fistula failure and angioplasty: intimal hyperplasia and other causes of access failure10.1053/j.ajkd.2016.08.025 ↗
7. The cholesteryl ester transfer protein inhibitor, des-Fluoro-Anacetrapib, prevents vein bypass-induced neointimal hyperplasia in New Zealand white rabbits
8. Peptide vaccine against ADAMTS-7 ameliorates atherosclerosis and postinjury neointima hyperplasia10.1161/CIRCULATIONAHA.122.061516 ↗
9. Aorta remodelling associated with calcitonin gene related peptide concentration in rats with arterial hypertension10.2754/avb200978040595 ↗
10. Hemodynamic and biologic determinates of arteriovenous fistula outcomes in renal failure patients10.1155/2015/171674 ↗
11. Physiology and pathophysiology of vascular signaling controlled by guanosine 3',5'-cyclic monophosphate-dependent protein kinase10.1161/01.CIR.0000094403.78467.C3 ↗
12. PDF-ECG in clinical practice: a model for long-term preservation of digital 12-lead ECG data10.1016/j.jelectrocard.2017.08.001 ↗
13. The role of H2S bioavailability in endothelial dysfunction10.1016/j.tips.2015.05.007 ↗
14. Beyond a gasotransmitter: hydrogen sulfide and polysulfide in cardiovascular health and immune response10.1089/ars.2017.7096 ↗
15. The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide10.1006/bbrc.1997.6878 ↗
16. Vascular tissue engineering: polymers and methodologies for small caliber vascular grafts
17. Simultaneous determination of sodium iron chlorophyllin and sodium copper chlorophyllin in food using high-performance liquid chromatography and ultra-performance liquid chromatography-mass spectrometry10.1016/j.foodchem.2018.10.015 ↗
18. Chlorophyllin supplementation modulates hyperglycemia-induced oxidative stress and apoptosis in liver of streptozotocin-administered mice10.1002/biof.1438 ↗
19. Copper-incorporated collagen/catechol film for in situ generation of nitric oxide10.1021/acsbiomaterials.5b00131 ↗
20. Cellulose-based biomaterials integrated with copper-cystine hybrid structures as catalysts for nitric oxide generation10.1016/j.msec.2019.110369 ↗
21. Hydrogen sulfide-releasing polyurethane/gelatin/keratin-TA conjugate mats for wound healing10.1039/D2TB01700H ↗
22. Hemodynamic influence on smooth muscle cell kinetics and phenotype during early vein graft adaptation10.1007/s10439-016-1725-0 ↗
23. Hydrogen sulfide, an enhancer of vascular nitric oxide signaling: mechanisms and implications10.1152/ajpcell.00282.2016 ↗
24. Nitrite therapy ameliorates myocardial dysfunction via H2S and nuclear factor-erythroid 2-Related factor 2 (Nrf2)-Dependent signaling in chronic heart failure10.1161/JAHA.116.003551 ↗
25. Multifunctional antibiotics-free hydrogel dressings with self-regulated nitric oxide-releasing kinetics for improving open wound healing10.1039/D2TB02671F ↗
26. Cellular energy supply for promoting vascular remodeling of small-diameter vascular grafts: a preliminary study of a new strategy for vascular graft development10.1039/D2BM01338J ↗
27. Evaluation of mechanical properties and biocompatibility of three-layer PCL/PLLA small-diameter vascular graft with pore diameter gradient10.1016/j.eurpolymj.2023.111864 ↗
28. Reconstituted HDL-apoE3 promotes endothelial cell migration through ID1 and its downstream kinases ERK1/2, AKT and p38 MAPK10.1016/j.metabol.2021.154954 ↗
29. Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway10.1186/s13046-017-0495-3 ↗
30. MG-132 activates sodium palmitate-induced autophagy in human vascular smooth muscle cells and inhibits senescence via the PI3K/AKT/mTOR axis10.1186/s12944-024-02268-w ↗
31. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy10.1038/s41573-021-00233-1 ↗
32. In vitro antioxidant activities of sodium zinc and sodium iron chlorophyllins from pine needles10.17113/ftb.52.04.14.3592 ↗
33. Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype10.1002/emmm.201201374 ↗
34. Atherosclerotic plaque destabilization: mechanisms, models, and therapeutic strategies10.1161/CIRCRESAHA.114.302355 ↗
35. In situ flow MAS NMR spectroscopy and synchrotron PDF analyses of the local response of the bronsted acidic site in SAPO-34 during hydration at elevated temperatures10.1002/cphc.201700973 ↗
36. Pathophysiology of vascular calcification: pivotal role of cellular senescence in vascular smooth muscle cells10.1016/j.exger.2010.07.005 ↗
37. Nitric oxide prevents aortic valve calcification by S-nitrosylation of USP9X to activate NOTCH signaling10.1126/sciadv.abe3706 ↗
38. Hydrogen sulfide as an anti-calcification stratagem in human aortic valve: altered biogenesis and mitochondrial metabolism of H2S lead to H2S deficiency in calcific aortic valve disease10.1016/j.redox.2023.102629 ↗
39. Hydrogen sulfide prevents arterial medial calcification in rats with diabetic nephropathy10.1186/s12872-021-02307-9 ↗
40. Construction of enzyme-laden vascular scaffolds based on hyaluronic acid oligosaccharides-modified collagen nanofibers for antithrombosis and in-situ endothelialization of tissue-engineered blood vessels10.1016/j.actbio.2022.09.041 ↗
41. Anti-thrombogenic properties of a nitric oxide-releasing dextran derivative: evaluation of platelet activation and whole blood clotting kinetics10.1039/c3ra45521a ↗
42. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle10.1038/368850a0 ↗
43. Hybrid electrospun rapamycin-loaded small-diameter decellularized vascular grafts effectively inhibit intimal hyperplasia10.1016/j.actbio.2019.06.037 ↗
44. Platelet inhibition and endothelial cell adhesion on elastin-like polypeptide surface modified materials10.1016/j.biomaterials.2011.04.067 ↗
45. Two-pronged microbe delivery of nitric oxide and oxygen for diabetic wound healing10.1021/acs.nanolett.3c01023 ↗
46. Nitric-oxide-releasing biomaterial regulation of the stem cell microenvironment in regenerative medicine10.1002/adma.201805818 ↗
47. Trends in H2S-Donors chemistry and their effects in cardiovascular diseases10.3390/antiox10030429 ↗
48. Bilayer vascular grafts separately composited with nitric oxide-releasing keratin conjugates and hydrogen sulfide-releasing heparin conjugates
49. Bilayer vascular grafts with on-demand NO and H2S release capabilities
50. Endothelium-mimicking bilayer vascular grafts with dual-releasing of NO/H2S for anti-inflammation and anticalcification10.1021/acsami.3c15176 ↗
51. Nitric oxide-releasing poly(epsilon-caprolactone)/S-nitrosylated keratin biocomposite scaffolds for potential small-diameter vascular grafts10.1016/j.ijbiomac.2021.08.147 ↗
52. Novel H(2)S-NO hybrid molecule (ZYZ-803) promoted synergistic effects against heart failure10.1016/j.redox.2017.11.020 ↗
53. Intrauterine nitric oxide deficiency weakens differentiation of vascular smooth muscle in newborn rats10.3390/ijms22158003 ↗
54. Hydrogen sulfide facilitates the impaired sensitivity of carotid sinus baroreflex in rats with vascular calcification10.3389/fphar.2017.00629 ↗
55. The influence of textile structure characteristics on the performance of artificial blood vessels10.3390/polym15143003 ↗
56. 3D micro-nano hierarchical constructs enabling transmural ingrowth of adventitia improves the “Fallout endothelialization”of vascular grafts10.1002/adfm.202416702 ↗
57. Long term performance of polycaprolactone vascular grafts in a rat abdominal aorta replacement model10.1016/j.biomaterials.2011.09.024 ↗
58. Vascular calcification: mechanisms of vascular smooth muscle cell calcification, trends cardiovasc
59. Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia
60. Vascular calcification-new insights into its mechanism10.3390/ijms21082685 ↗
61. Biomimetic tri-layered small-diameter vascular grafts with decellularized extracellular matrix promoting vascular regeneration and inhibiting thrombosis with the salidroside
62. Bilayered polymeric Micro- and nanofiber vascular grafts as abdominal aorta replacements: long-term in vivo studies in a rat model10.1021/acsabm.9b00641 ↗
63. The effect of pore diameter on neo-tissue formation in electrospun biodegradable tissue-engineered arterial grafts in a large animal model10.1016/j.actbio.2020.08.011 ↗
64. Influence of pore architectures of silk fibroin/collagen composite scaffolds on the regeneration of osteochondral defects in vivo10.1039/C9TB01558B ↗
65. Endothelium-mimicking bilayer vascular grafts with dual-releasing of NO/H2S for anti-inflammation and anticalcification10.1021/acsami.3c15176 ↗
66. Status of glutathione and other thiols and disulfides in human plasma10.1016/S0006-2952(00)00293-8 ↗